Ignite Creation Date:
2024-05-06 @ 1:23 AM
Last Modification Date:
2024-10-26 @ 11:03 AM
Study NCT ID:
NCT01797939
Status:
COMPLETED
Last Update Posted:
2013-02-25
First Post:
2013-02-21
Brief Title:
Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients
Sponsor:
Seoul National University Bundang Hospital
Organization:
Seoul National University Bundang Hospital
Study Overview
Official Title:
Predictive Factors of Response to Proton Pump Inhibitor Treatment in Patients With Gastroesophageal Reflux Disease Symptoms
Status:
COMPLETED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Proton pump inhibitor PPI is widely used in patients with gastroesophageal reflux disease GERD however some patients fail to respond to PPI therapy Recent reporters suggest that depressive disorders anxiety sleep dysfunction were related with the symptomatic responses to a PPI treatments Nevertheless the predictive factors of response to PPI treatment still remain controversial Therefore the aims of this study were to investigate the efficacy of PPI therapy and to evaluate the predictors of the PPI response in patients with symptomatic GERD by using the questionnaire which consisted of GERD symptoms GERD impact scale GIS Epworth sleepiness scale ESS Pittsburgh sleep quality index PSQI Hospital anxiety and depression scale HADS and WHO quality of life scale abbreviated version WHOQOL-BREF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None